Related Experiment Videos
Do surrogate decision makers provide accurate consent for intensive care research?
1Department of Medicine, Kaiser Medical Center, San Francisco, CA 94115, USA. Michael.Coppolino@ncal.kaiperm.org
Context:
ICU patients are often rendered incapable of making decisions as a result of their illness. The accuracy with which patients' surrogates consent to research on their behalf is not known.
Objective:
To determine if surrogate decision makers provide accurate consent for intensive care research.
Design:
Cross-sectional, paired, face-to-face interviews.
Setting:
A large, managed-care, cardiac surgery service. PATIENTS AND PATICIPANTS: One hundred elective cardiac surgery patients and their self-appointed surrogates were enrolled.
Intervention:
Patients agreed or declined to provide informed consent to two hypothetical research trials. One trial represented minimal risk to those enrolled; the other trial represented greater-than-minimal risk. Surrogates attempted to predict the patients' responses.
Main Outcome Measures:
The accuracy of surrogate consent was analyzed in a fashion analogous to the evaluation of a diagnostic test. Predictors of accuracy were evaluated using multiple logistic regression.
Results:
Overall surrogate positive predictive value for the low-risk study was 84.0% and for the high-risk study was 79.7% (p = 0.72, McNemar test). Predictors of accurate consent were not consistent across the two studies.
Conclusions:
Surrogate decision makers for critical-care research resulted in false-positive consent rates of 16 to 20.3%. Further assessment and evaluation of the practice of surrogate consent for intensive care research is, therefore, recommended.